Magnetic resonance imaging in the early diagnosis of group a β streptococcal necrotizing fasciitis: A case report

Journal of Emergency Medicine

Volumn 16, Issue 3, 1998, Pages 403-407

  Drake, David B ^a   Woods, Julia A ^a   Bill, Timothy J ^a   Kesser, Bradley W ^a   Wenger, Mark A ^a   Neal, Jeffrey G ^a   Edlich, Richard F ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Clindamycin group A streptococcal infection; Magnetic resonance imaging; Necrotizing fasciitis; Skin sparing; Streptococcal toxic shock syndrome; Streptococcus pyogenes

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; IMMUNOGLOBULIN;

ADULT; ARTICLE; CASE REPORT; DEBRIDEMENT; EARLY DIAGNOSIS; HUMAN; HYPERBARIC OXYGEN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NECROTIZING FASCIITIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

BIOPSY, NEEDLE; EMERGENCIES; FASCIITIS, NECROTIZING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; STREPTOCOCCUS PYOGENES; TIME FACTORS;

EID: 0032076135     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(98)00013-4     Document Type: Article

References (31)

1. 1. Davies HD, McGeer A, Schwartz B, et al. Ontario group A streptococcal study group. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med. 1996;335:547-4.
2. 2. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. JAMA. 1993;269:384-9.
3. 3. Wilson B. Necrotizing fasciitis. Am Surg. 1952;18:416-31.
4. 4. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis. 1992;14:2-13.
5. 5. Stevens DL. Invasive group A streptococcal disease. J Infect Dis. 1996;5:157-66.
6. 6. Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotizing fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet. 1994;344:1111-5.
7. 7. Namias N, Martin L, Matos L, Sleeman D, Snowdon B. Symposium: necrotizing fasciitis. Contemp Surg. 1996;49: 167-78.
8. 8. Lille ST, Sato TT, Engrav LH, Foy H, Jurkovich GJ. Necrotizing soft tissue infections: obstacles in diagnosis. J Am Coll Surg. 1996;182:7-11.
9. 9. Beltran J, Noto AM, McGhee RB, et al. Infections of the musculoskeletal system: high-field strength MR imaging. Radiology. 1987;164:449-54.
10. 10. Tang JHS, Gold RH, Bassett LW, Seeger LL. Musculoskeletal infection of the extremities. Radiology. 1988;166:205-9.
11. 11. Sharif HS, Clark DC, Aabed MY, Aideyan OA, Haddad MC, Mattsson TA. MR imaging of thoracic and abdominal wall infections: comparison with other imaging procedures. Am J Roentgenol. 1990;154:989-5.
12. 12. Rahmouni A, Chosidow O, Mathieu D, et al. MR imaging in acute infectious cellulitis. Radiology. 1994;192:493-6.
13. 13. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA. 1993;269:390-1.
14. 14. Francis J, Warren RE. Streptococcus pyogenes bacteria in Cambridge: a review of 67 episodes. Q J Med. 1988;256:603-13.
15. 15. Stevens DL, Yan S, Bryant AE. Penicillin binding protein expression at different growth stages determines penicilllin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis. 1993;167:1401-5.
16. 16. Yan S, Bohach GA, Stevens DL. Persistent acylation of high-molecular weight penicillin binding proteins by penicillin induces the post antibiotic effect in Streptococcus pyogenes. J Infect Dis. 1994;170:609-14.
17. 17. Gemmell CG, Peterson PK, Schmeling D, et al. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest. 1981;67: 1249-56.
18. 18. Stevens DL, Maier KA, Mitten JE. Effect of antibiotics on toxin production and viability of Clostidium perfringens. Antimicrob Agents Chemother. 1987;31:213-8.
19. 19. Stevens DL, Bryant AE, Yan S. Invasive group A streptococcal infection:.new concepts in antibiotic treatment. Int J Antimicrob Agents. 1994;4:297-301.
20. 20. Stevens DL, Bryant AE, Hackett SP. Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis. 1995;20:S154-7.
21. 21. Meleney FL. Hemolytic streptococcus gangrene. Arch Surg. 1924; 9:317-64.
22. 22. Sudarsky LA, Laschinger JC, Coppa GF, Spencer FC. Improved results form standardized approach in treating patients with necrotizing fasciitis. Ann Surg. 1987;206:661-5.
23. 23. Wang KC, Shih CH. Necrotizing fasciitis of the extremities. J Trauma. 1992;32:179-82.
24. 24. Kaufman JL. Clinical problem-solving: necrotizing fasciitis. N Engl J Med. 1994;331:279-80. Letter.
25. 25. Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR. Streptococcal myositis. Arch Intern Med. 1985; 145:1020-3.
26. 26. Riseman JA, Zamboni AZ, Curtis A, et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990;108:847-50.
27. 27. Brown DR, Davis NL, Lepawsky M, et al. A multicenter review of the treatments of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167:485-9.
28. 28. Monestersky JH, Myers RAM. Hyperbaric oxygen treatment of necrotizing fasciitis. Am J Surg. 1995;169:187-8.
29. 29. Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest. 1996;110:219-29.
30. 30. Barry W, Hudgins L, Donta S, Pesanti E. i.v. immunoglobulin therapy for toxic shock syndrome. JAMA. 1992;267:3315-6.
31. 31. Yong JM. Necrotizing fasciitis. Letter. Lancet. 1994;343:1427.